PEC vs Foresee Pharmaceuticals: monthly revenue

Monthly revenue and year-on-year change for PEC (6446) and Foresee Pharmaceuticals (6576) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ PEC ━ Foresee Pharmaceuticals

0%+750%-81%25/1026/0126/0426/0726/10

Monthly revenue history

MonthPECYoYForesee PharmaceuticalsYoY
Oct 2026NT$2.84 billion+102.0%NT$125.1 million+397.5%
Sep 2026NT$2.64 billion+100.0%NT$6.3 million-1.1%
Aug 2026NT$2.62 billion+105.4%NT$26.7 million-81.1%
Jul 2026NT$2.51 billion+92.6%NT$30.3 million+242.1%
Jun 2026NT$2.33 billion+94.9%NT$10.9 million-71.8%
May 2026NT$2.46 billion+108.5%NT$118.5 million+749.6%
Apr 2026NT$2.06 billion+68.3%NT$52.2 million-11.2%
Mar 2026NT$1.94 billion+64.4%NT$40.4 million+42.5%
Feb 2026NT$1.6 billion+56.7%NT$27.1 million-61.8%
Jan 2026NT$1.58 billion+49.8%NT$12.8 million+14.8%
Dec 2025NT$1.92 billion+69.9%NT$14.1 million-6.5%
Nov 2025NT$1.55 billion+53.0%NT$13 million+34.3%
Oct 2025NT$1.4 billion+53.6%NT$25.2 million-78.3%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-17